发明名称
摘要 <p>Certain piperazinyl and piperidinyl urea compounds are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity. Thus, the compounds may be administered to treat, e.g., anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders (such as multiple sclerosis).</p>
申请公布号 JP2008526755(A) 申请公布日期 2008.07.24
申请号 JP20070549603 申请日期 2005.12.29
申请人 发明人
分类号 C07D207/335;A61K31/135;A61K31/167;A61K31/192;A61K31/195;A61K31/197;A61K31/445;A61K31/495;A61K31/496;A61K31/498;A61K31/506;A61K31/616;A61K45/00;A61P1/04;A61P1/08;A61P1/12;A61P1/14;A61P1/16;A61P3/00;A61P3/10;A61P9/00;A61P9/12;A61P11/04;A61P15/08;A61P15/18;A61P17/04;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P31/18;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D209/14;C07D209/86;C07D211/14;C07D213/36;C07D213/75;C07D215/12;C07D239/42;C07D241/42;C07D295/20;C07D307/81;C07D317/58;C07D319/18;C07D333/58;C07D401/12;C07D405/12;C07D417/12 主分类号 C07D207/335
代理机构 代理人
主权项
地址